Psychiatry and Neurology, Neurology · Chalmette, LA
NPI
1629023908
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
2116 Pakenham Dr
Chalmette, LA, 70043
Phone (504) 301-1468
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
9,816 services
Medicare patients, 2024
72
Average age 69
Drug cost, 2024
$867K
2,688 prescriptions
Company payments, 2025
$3,819
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carol R Redillas was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,400 times for 16 patients. In total Carol R Redillas billed 9,816 services in 22 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,400 | 16 | $4.98 | $47K |
| 99214 Office E&M - Established | Office | 148 | 55 | $78.11 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 46 | $12.63 | $985 |
| 64615 Musculoskeletal | Office | 62 | 20 | $105.76 | $6,557 |
| 99215 Office E&M - Established | Office | 50 | 20 | $102.96 | $5,148 |
By year: 2022 $70K for 6,035 services; 2023 $74K for 8,754 services; 2024 $76K for 9,816 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carol R Redillas prescribed most often to Medicare patients was Sumatriptan Succinate, with 144 prescriptions and refills. In total Carol R Redillas wrote 2,688 Medicare prescriptions that cost $867K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 144 | 165 | 28 | $5,345 |
| Topiramate Generic | 115 | 250 | 35 | $3,248 |
| Butorphanol Tartrate Generic | 105 | 105 | Under 11 | $6,414 |
| Memantine Hcl Generic | 67 | 143 | 16 | $1,360 |
| Ubrelvy Ubrogepant | 66 | 66 | 15 | $89K |
| Donepezil Hcl Generic | 60 | 135 | 21 | $412 |
| Rizatriptan Rizatriptan Benzoate | 60 | 60 | 11 | $546 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 55 | 55 | Under 11 | $957 |
| Qulipta Atogepant | 54 | 56 | Under 11 | $60K |
| Propranolol Hcl Generic | 54 | 96 | 18 | $528 |
| Gabapentin Generic | 52 | 110 | 13 | $1,054 |
| Primidone Generic | 50 | 90 | 12 | $1,508 |
| Ondansetron Odt Ondansetron | 47 | 47 | 13 | $224 |
| Trazodone Hcl Generic | 46 | 93 | Under 11 | $521 |
| Ibuprofen Generic | 46 | 46 | Under 11 | $116 |
Brand drugs: - claims; generic drugs: 2,213 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carol R Redillas $3,819 ($3,400 in general payments such as food, travel and fees and $419 for research) from 14 companies. The largest payer was Ipsen Innovation with $1,357.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.